Form 4 for ISRG Intuitive Surgical
Accepted 2021-08-09 00:00:00 ET · period of report 2021-08-05 · accession 0001567619-21-014785 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-09 | 2021-08-05+ | ISRG | Rosa David J. | EVP, Chief Business Off | S - Sale+OE | $1,009.55 | -16.2K | 37.5K | -30% | -$16.37M |
| DM | 2021-08-09 | 2021-08-05+ | ISRG | Rosa David J. | EVP, Chief Business Off | M - OptEx | $172.44 | +21.0K | 45.6K | +85% | +$3.62M |
| DM | 2021-08-09 | 2021-08-05+ | ISRG | Rosa David J. | EVP, Chief Business Off | M - OptEx | $0.00 | -21.0K | 10.5K | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-05 | S | D | 8,146 | $1,007.23 | 35,066 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $997.81 to $1,009.99, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2021-08-05 | M | A | 10,500 | $172.44 | 43,212 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-06 | M | A | 10,500 | $172.44 | 45,566 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-06 | S | D | 8,065 | $1,011.90 | 37,501 | D | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,007.24 to $1,020.59, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-06 | M | D | 10,500 | $0.00 | 0 | D | $172.44 · — to 2022-08-15 | 10,500 Common Stock | (F4) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-05 | M | D | 10,500 | $0.00 | 10,500 | D | $172.44 · — to 2022-08-15 | 10,500 Common Stock | (F4) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |